Medicine & pharmacy

Amerikaanse FDA keurt tabletformulering van BeOne’s BRUKINSA® goed voor alle goedgekeurde indicaties

Nieuwe formulering biedt patiënten een vereenvoudigde dosering – waardoor de pillast wordt verminderd en het toedieningsgemak wordt vergroot – met behoud van flexibele doseringsopties SAN...

Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva’s flagship spin-off

GENEVA–(BUSINESS WIRE)– The Wyss Center for Bio and Neuroengineering proudly announces the appointment of Craig Cook, former Head of Business Development & Licensing at the...

Mehiläinen Yhtiöt Oy Announces Pricing of Senior Secured Notes Offering

HELSINKI–(BUSINESS WIRE)– THIS INFORMATION RELATES TO AN OFFERING OF SECURITIES OFFERED AND SOLD PURSUANT TO RULE 144A AND/OR REGULATION S (EXEMPTIONS FROM THE U.S. REGISTRATION...

Stallergenes Greer Showcases Developments in Respiratory and Food Allergy Care at EAACI 2025

BAAR, Switzerland–(BUSINESS WIRE)– Stallergenes Greer, a global leader in allergy therapeutics, will present insightful scientific developments at the European Academy of Allergy and Clinical Immunology...

Samsung Bioepis Presents Long-Term Safety Data of EPYSQLI™ (Eculizumab) in PNH at the European Hematology Association (EHA) Congress 2025

Long-term follow-up of EPYSQLI’s Phase 3 study showed consistency of safety data between the initial 52-week period and the extended treatment period up to 158...

U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications

New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of administration—while preserving flexible dosing options SAN CARLOS, Calif.–(BUSINESS WIRE)– BeOne...

Sofinnova Partners Collaborates With NVIDIA to Accelerate European Life Sciences Startups

Delivers high-performing AI infrastructure through NVIDIA DGX Cloud Lepton to portfolio companies, creating a powerful competitive advantage in $100B+ life sciences market BioCorteX, Bioptimus, Cure51,...

BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025

SAN CARLOS, Calif.–(BUSINESS WIRE)– BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that it will host an Investor...

HistoSonics en Cambridge University onthullen het eerste Edison™ Histotripsy System van Europa, dankzij een schenking van de Li Ka Shing Foundation

Deze mijlpaal markeert de initiële marktintroductie van het bedrijf in het Verenigd Koninkrijk na de UCNA-goedkeuring (Unmet Clinical Needs Authorization) toegekend door MHRA MINNEAPOLIS–(BUSINESS WIRE)–...

Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer

PLATTSBURGH, N.Y.–(BUSINESS WIRE)– Medisca and FlackTek have reached a settlement to resolve their patent dispute relating to the Medisca MAZ® mixer and related mixing technologies...

Novotech Showcased in Global Biotech Series for Innovation in Hepatitis B Research

SYDNEY–(BUSINESS WIRE)– Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series...

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

EEG-Guided Anesthesia Using Masimo Technology Significantly Reduced Pediatric Anesthesia Emergence Delirium, Time to Emergence and Discharge, and Cost of Care by Minimizing Sevoflurane Exposure NEUCHATEL,...

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults

In laboratory studies, zoliflodacin has been shown to be active against Neisseria gonorrhoeae including multidrug-resistant strains. If approved, zoliflodacin could become the first new antibiotic...

HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift

Milestone marks company’s initial entry into the United Kingdom, following Unmet Clinical Needs Authorization (UCNA) Approval by MHRA MINNEAPOLIS–(BUSINESS WIRE)– HistoSonics, the manufacturer of the...

KuppingerCole erkent Regula als een innovatieleider op het gebied van identiteitsverificatie

RESTON, Va.–(BUSINESS WIRE)– Regula, een wereldwijde ontwikkelaar van forensische apparaten en oplossingen voor identiteitsverificatie (IDV), is voor het eerst opgenomen in de KuppingerCole Leadership Compass...